Northern Jiangsu People's Hospital

This study is testing whether a combination of a traditional Chinese medicine capsule (Icaritin) and a specialized form of chemotherapy delivered directly to the liver can help prevent liver cancer from returning after surgery. It is for patients who have had their tumor surgical…

This study is testing if the blood-thinning medication apixaban is safe and effective at dissolving blood clots that form in a major liver vein more than a year after spleen removal surgery. It involves 20 patients with liver cirrhosis who develop this specific type of clot. Doct…

This study is testing whether adding a second steroid (fludrocortisone) to a standard one (hydrocortisone) helps adults with life-threatening septic shock. It will compare the two-drug combination against standard care in 336 patients. The main goal is to see if the combination i…

This study is testing whether combining an immunotherapy drug (tislelizumab) with targeted radiation before surgery can help shrink or eliminate tumors in people with operable non-small cell lung cancer. The goal is to see if this pre-surgery treatment makes the cancer easier to …

This study is testing whether delivering a specific chemotherapy regimen directly into the liver's artery after surgery can help prevent liver cancer from coming back in patients at high risk of recurrence. It will enroll about 30 adults who have recently had successful surgery t…

This study is comparing two types of minimally invasive spleen surgery for people with advanced liver disease. Researchers want to see if removing only part of the spleen, instead of the whole organ, helps patients' immune systems recover better after surgery. They will measure b…

This study aims to understand why some people with diabetes develop gastroparesis, a condition where the stomach muscles don't work properly, causing nausea and bloating. Researchers will compare blood and stomach tissue samples from 50 people with diabetic gastroparesis to sampl…